Acadia Pharmaceuticals has secured an exclusive global licence from Saniona to develop and commercialise SAN711.

Arrowhead has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics for rare genetic disease ...

The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.

Eton has acquired the rights in the US to Amglidia for neonatal diabetes mellitus, from French biotechnology company AMMTeK.

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the ...